We are very pleased to inform you that the 8th edition of MATWIN’s international board has awarded PDC*line Pharma with the prize of most promising project in the “start-up” category.
This prize...
Three Belgian investment funds and several specialized international business angels have participated in this round, which will allow the company’s cancer immunotherapy technology to reach the...
From right to left: Isabelle Tabah-Fisch (CMO), Laurent Levy (CEO) and Joel Plumas...
PDC*line Pharma received €500 k in grants and won 3 awards in 2014: the Worldwide Innovation Challenge 2030, the i-Lab French competition, and the French plan “medical biotechs”.
PDC*line pharma has been declared as a national winner of the 2014 edition of the French competition for creation of innovative companies, in the “creation – development” category.
